Mobile

An international multicentre, randomized, parallel group, double-blind trial to evaluate different dose combinations of lercanidipine and enalapril in comparison with each component administered alone...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-015988-13

An international multicentre, randomized, parallel group, double-blind trial to evaluate different dose combinations of lercanidipine and enalapril in comparison with each component administered alone and with placebo in patients with essential hypertension

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to evaluate the optimal dose combinations of lercanidipine and enalapril as initial treatment of patients with moderate essential hypertension.

Critère d'inclusion

  • essential hypertension

Liens